UNBX (Unity Biotechnology) OCF Margin %: 0.00% (As of Mar. 2025)


What is Unity Biotechnology OCF Margin %?

Unity Biotechnology UNBX OCF Margin % is 0.00% as of Mar. 2025.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Unity Biotechnology's Cash Flow from Operations for the three months ended in Mar. 2025 was $-6.36 Mil. Unity Biotechnology's Revenue for the three months ended in Mar. 2025 was $0.00 Mil. Therefore, Unity Biotechnology's OCF Margin % for the quarter that ended in Mar. 2025 was 0.00%.

As of today, Unity Biotechnology's current OCF Yield % is -2,281.47%.

The historical rank and industry rank for Unity Biotechnology's OCF Margin % or its related term are showing as below:


During the past 9 years, the highest OCF Margin % of Unity Biotechnology was -941.89%. The lowest was -22209.32%. And the median was -2775.54%.

UNBX's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Unity Biotechnology OCF Margin % Related Terms

Unity Biotechnology OCF Margin % Historical Data

* Premium members only.

The historical data trend for Unity Biotechnology's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unity Biotechnology OCF Margin % Chart

Unity Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 -941.89 -22,209.32 0.00 0.00

Unity Biotechnology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Unity Biotechnology OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Unity Biotechnology's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-20.865/0
= %

Unity Biotechnology's OCF Margin for the quarter that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-6.357/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Unity Biotechnology (UNBX) has a OCF Margin % of 0.00% as of Mar. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Unity Biotechnology and its competitors.
Is Unity Biotechnology's OCF Margin % too high?
Unity Biotechnology's current OCF Margin % is 0.00%.
How does Unity Biotechnology's OCF Margin % compare to ADTX and HEPA?
Unity Biotechnology's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Unity Biotechnology and its competitors. Unity Biotechnology's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unity Biotechnology stock overvalued right now?
Unity Biotechnology (UNBX) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Unity Biotechnology (UNBX), the current OCF Margin % is 0.00% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Unity Biotechnology Business Description

Address 285 East Grand Avenue, South San Francisco, CA, USA, 94080
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.